179 related articles for article (PubMed ID: 34967506)
21. Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli M; Turan V; Gungorduk K; Hasdemir P; Tosun G; Dogan A; Ozdemir A; Adiyeke M; Sanci M
Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):81-6. PubMed ID: 25688821
[TBL] [Abstract][Full Text] [Related]
22. [Value of magnetic resonance imaging in preoperative staging of endometrial carcinoma according to International Federation of Gynecology and Obstetrics (2009) staging criteria].
Du L; Lei Y; Li D; Qiu X; Liang B
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1048-51. PubMed ID: 22820597
[TBL] [Abstract][Full Text] [Related]
23. The role of para-aortic lymphadenectomy in stage IIIC endometrial cancer: A single-institute study.
Kikuchi A; Yanase T; Sasagawa M; Honma S
J Obstet Gynaecol; 2017 May; 37(4):510-513. PubMed ID: 28421906
[TBL] [Abstract][Full Text] [Related]
24. [Impact of 2009 FIGO staging system on the diagnostic value of preoperative MRI staging of endometrial carcinoma].
Yu XD; Ouyang H; Lin M; Zhou CW; Zhang R
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):692-6. PubMed ID: 22340052
[TBL] [Abstract][Full Text] [Related]
25. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for cervical stromal involvement in endometrioid-type endometrial cancer.
Toprak S; Sahin EA; Sahin H; Tohma YA; Yilmaz E; Meydanli MM
Int J Gynaecol Obstet; 2021 Apr; 153(1):51-55. PubMed ID: 33118165
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance imaging (MRI) in endometrial carcinoma; preoperative estimation of depth of myometrial invasion.
Minderhoud-Bassie W; Treurniet FE; Koops W; Chadha-Ajwani S; Hage JC; Huikeshoven FJ
Acta Obstet Gynecol Scand; 1995 Nov; 74(10):827-31. PubMed ID: 8533569
[TBL] [Abstract][Full Text] [Related]
28. Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments.
Mitamura T; Watari H; Todo Y; Kato T; Konno Y; Hosaka M; Sakuragi N
J Gynecol Oncol; 2014 Oct; 25(4):301-5. PubMed ID: 25142623
[TBL] [Abstract][Full Text] [Related]
29. Predictive ability of maximal tumor diameter on MRI for high-risk endometrial cancer.
Bourgioti C; Chatoupis K; Tzavara C; Antoniou A; Rodolakis A; Moulopoulos LA
Abdom Radiol (NY); 2016 Dec; 41(12):2484-2495. PubMed ID: 27714421
[TBL] [Abstract][Full Text] [Related]
30. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
Cosgrove CM; Cohn DE; Rhoades J; Felix AS
Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging to identify risk of lymph node metastasis in patients with endometrial cancer.
Undurraga M; Petignat P; Pelte MF; Jacob S; Dubuisson JB; Loubeyre P
Int J Gynaecol Obstet; 2009 Mar; 104(3):233-5. PubMed ID: 19036368
[TBL] [Abstract][Full Text] [Related]
32. Preoperative Assessment of Myometrial Invasion in Endometrial Cancer by 3D Ultrasound and Diffusion-Weighted Magnetic Resonance Imaging: A Comparative Study.
Rodríguez-Trujillo A; Martínez-Serrano MJ; Martínez-Román S; Martí C; Buñesch L; Nicolau C; Pahisa J
Int J Gynecol Cancer; 2016 Jul; 26(6):1105-10. PubMed ID: 27177278
[TBL] [Abstract][Full Text] [Related]
33. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
[TBL] [Abstract][Full Text] [Related]
34. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
Chi DS; Barakat RR; Palayekar MJ; Levine DA; Sonoda Y; Alektiar K; Brown CL; Abu-Rustum NR
Int J Gynecol Cancer; 2008; 18(2):269-73. PubMed ID: 18334008
[TBL] [Abstract][Full Text] [Related]
35. Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment.
Barlin JN; Soslow RA; Lutz M; Zhou QC; St Clair CM; Leitao MM; Iasonos A; Hensley ML; Barakat RR; Matias-Guiu X; Abu-Rustum NR
Int J Gynecol Cancer; 2013 Nov; 23(9):1620-8. PubMed ID: 24126219
[TBL] [Abstract][Full Text] [Related]
36. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
Lax SF; Tamussino KF; Lang PF
Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
[TBL] [Abstract][Full Text] [Related]
37. Preoperative ultrasound study in predicting lymph node metastasis for endometrial cancer patients.
Cheng WF; Chen CA; Lee CN; Chen TM; Huang KT; Hsieh CY; Hsieh FJ
Gynecol Oncol; 1998 Dec; 71(3):424-7. PubMed ID: 9887243
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer.
Han SS; Lee SH; Kim DH; Kim JW; Park NH; Kang SB; Song YS
Acta Obstet Gynecol Scand; 2010; 89(2):168-74. PubMed ID: 19916890
[TBL] [Abstract][Full Text] [Related]
39. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
[TBL] [Abstract][Full Text] [Related]
40. [Endometrial cancer: what's new?].
Narducci F; Lambaudie E; Sonoda Y; Papageorgiou T; Taïeb S; Cabaret V; Castelain B; Leblanc E; Querleu D
Gynecol Obstet Fertil; 2003; 31(7-8):581-96. PubMed ID: 14563602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
